Raising awareness of the racial disparities in the impact of colorectal cancer on the Black community.

HRES 239 is a non-binding resolution recognizing racial disparities in colorectal cancer (CRC) outcomes, specifically highlighting that Black Americans face 20% higher CRC rates and 40% higher death rates compared to non-Hispanic Whites. It directly affects Black communities disproportionately impacted by these disparities, which include the lowest 5-year survival rate for CRC. The resolution encourages the CDC to research screening disparities and develop strategies to eliminate them, promotes adherence to U.S. Preventive Services Task Force screening guidelines, and urges states to expand coverage for early CRC screenings, particularly for Black individuals and other high-risk groups. It does not create new laws but aims to raise awareness and guide existing public health efforts.